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Article / Clinical Case Report
ABSTRACT
Cholesterol crystal embolism is a rare and easily overlooked cause of colonic ischemia. The gastrointestinal tract is the 
third most common organ system affected by cholesterol emboli, second only to kidney and skin. Here we present a 
catastrophic case of gastrointestinal cholesterol crystal embolism leading to extensive post-operative bowel infarction and 
ultimately death. For a practicing pathologist, careful attention to the vessels of any ischemic bowel and recognition of 
the subtle but distinct angular imprint of cholesterol crystals facilitates prompt identification of the atheroemboli. In some 
cases, early identification may help mitigate further tissue damage. In more acute and severe cases, identification of the 
cholesterol crystal emboli may be important primarily for documentation of procedural complications. 
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CASE REPORT
A 62-year-old man underwent bilateral common 
femoral endarterectomy and aortobifemoral bypass 
for severe claudication secondary to extensive 
atherosclerosis. On postoperative day 1, he developed 
melena and hematochezia. Emergency colonoscopy 
demonstrated severe ischemia of the proximal 
colon and severe circumferential ischemic proctitis. 
Due to severe hypoxia, hypotension, and lactic 
acidosis, exploratory laparotomy was performed 
on postoperative day 2. Necrosis of the distal ileum 
and cecum was identified, and these segments were 
subsequently resected. Dusky areas in the remainder 
of the small bowel and colon were left intact, pending 
future operative evaluation. On the following day, 
the patient developed multi-organ failure, and a 
second-look exploratory laparotomy was performed. 
Diffuse small bowel and ascending colon necrosis 
was identified, and these segments were resected. 
Intraoperatively, the patient became acidotic and 
hyperkalemic, and upon transport to the intensive care 
unit, the patient expired.
PATHOLOGIC RESULTS
Gross examination of the small bowel and colon 
resections revealed dusky serosa and dark red to grey 
mucosa with attenuated folds (Figure 1).
On the histologic sections, extensive mucosal and 
focal submucosal necrosis was present throughout 
the bowel (Figure 2). In the submucosa, numerous 
thin, needle-shaped clefts were noted in congested 
arterioles. Fibrin thrombi were also seen in some of 
the arterioles (Figure 2A). Additionally, focal areas of 
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DISCUSSION
Needle-shaped clefts are the characteristic imprint 
of cholesterol crystals. The cholesterol itself is no longer 
present, as it dissolves during tissue processing (due 
to serial incubations in ethanol and xylene). When the 
needle-shaped clefts are present in small blood 
vessels in association with histologic features of tissue 
ischemia, the findings are diagnostic of cholesterol 
crystal embolism (CCE).1-3 Fibrin thrombi develop 
secondarily as a result of obstructed blood flow.1,3
CCE also referred to as atheroembol ism 
or cholesterol embolization syndrome is a rare 
manifestation of the atherosclerotic disease.4 It occurs 
when an atherosclerotic plaque in the aorta or 
other major artery ruptures and releases cholesterol 
crystals and atheroma debris into the bloodstream. 
The crystals embolize to small and medium-sized 
arteries and arterioles, resulting in end-organ damage.1 
The location of the disrupted atherosclerotic plaque 
Figure 1. Ascending colon showing dusky mucosa 
with necrosis, hemorrhage, and attenuated folding 
(formalin-fixed specimen).
Figure 2. Photomicrograph of the ascending colon. A – Cholesterol crystal clefts (arrow) in an arteriole located 
in the submucosa of the cecum. Note the fibrin thrombus associated with the cholesterol crystal cleft. Mucosal 
necrosis is present; B – Cholesterol crystal clefts (arrows) in arterioles of varying sizes within the superficial and mid 
layers of the submucosa. (All images digitally scanned at 40X).
viable mucosa were noted on histologic sections. These 
areas were notable for absence of the aforementioned 
vascular changes.
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determines the pattern of end-organ damage and 
thus its clinical manifestations. CCE can occur upon 
spontaneous rupture of an atherosclerotic plaque, 
after iatrogenic mechanical trauma (e.g., vascular 
surgery, angiography, or angioplasty), or as a side 
effect of medications targeting the coagulation system 
(e.g., anticoagulants, or thrombolytics).5
The incidence of CCE is estimated to be less 
than 0.5% based on studies of unselected autopsy 
populations.6 However, it has been reported to be 
1.4% after coronary catheterization.7 The risk factors 
for cholesterol crystal formation are primarily those of 
atherosclerosis (e.g., smoking, hypercholesterolemia, 
hypertension, and obesity), while the risk factors for 
cholesterol crystal embolization include atherosclerosis, 
vascular  manipulat ion,  ant icoagulat ion,  and 
thrombolytic therapy.5,8
The gastrointestinal tract is the third most 
frequent organ system affected (13.4%), following 
kidney (31.5%) and skin (15.5%).6 Within the 
alimentary tract, the colon is the most common 
site of involvement (42.3%), followed by small 
intestine (33%), stomach (12.3%), rectum (9.2%), 
and esophagus (1.5%).9 CCE may also involve the 
pancreas, liver, and gallbladder.10,11 CCE involving 
the digestive tract often presents as abdominal pain, 
diarrhea, and gastrointestinal bleeding.5,8,12 Because 
the clinical presentation is not specific, the disease can 
masquerade as other conditions (e.g., infection, tumor, 
inflammatory bowel disease). CCE can present as either 
a chronic indolent disease that resolves over time or 
an acute catastrophic multi-organ disorder with poor 
prognosis.5 Although histologic evaluation is the gold 
standard for diagnosis, the co-occurrence of 3 clinical 
findings: (1) history of known risk factors for CCE (e.g., 
vascular surgery, anticoagulation), (2) acute onset 
renal failure with creatinine elevation of greater than 
50% of baseline, and (3) signs of cutaneous vascular 
compromise (e.g., livedo reticularis, purples toes) or 
funduscopic evidence of retinal atheroemboli, has 
proved to be relatively specific for disseminated CCE.13 
Thus, non-invasive procedures such as funduscopic 
examination can be useful. No specific treatment for 
CCE exists; however, early and aggressive supportive 
therapy (e.g., use of blood pressure lowering agents - in 
the context of cardiac failure, hemodialysis, nutritional 
support, discontinuation of inciting medications) can 
improve prognosis.13 Nonetheless, overall mortality 
rates are still as high as 80%.14
In the present case, the patient had multiple 
atherosclerotic plaques (identified by imaging) along 
the entire abdominal aorta, placing him at risk for 
multi-organ CCE. Indeed, besides the extensive 
gastrointestinal tract involvement, acute renal and liver 
failure emerged after aortobifemoral bypass. Although 
an autopsy was not performed, the widespread aortic 
atherosclerosis, diffuse bowel infarction, and acute 
renal and liver dysfunction point to multi-organ CCE 
as the ultimate cause of his demise. Nonetheless, 
since no post-surgical angiography studies were 
performed, we cannot entirely exclude the possibility 
that vasoconstriction of large arteries contributed 
to the vascular compromise, as has been described 
previously.15 It is also worth noting that the patient’s 
abdominal aorta clamp time (35 minutes) and blood 
loss (1.5 L) would be considered moderate16 and would 
not be expected to be the primary cause of the patient’s 
massive vascular compromise.
From a histologic standpoint, the differential 
diagnosis of colonic ischemia includes infection 
(e.g., cytomegalovirus, E. coli O157:H7), vasculitis, 
mesenteric ischemia due to prolonged aort ic 
clamping, mesenteric thrombosis, radiation-induced 
vasculopathy, mesenteric myointimal hyperplasia,17 
and enterocolic lymphocytic phlebitis,18 none of 
which were observed in this case. Additionally, a 
thrombus overlying an atheromatous plaque can 
become loose and occlude downstream large caliber 
arteries (thromboembolism).3,4,19 Thromboembolism 
is distinguished from CCE in that it usually involves a 
single target organ and the emboli are predominantly 
composed of fibrin, whereas CCE is characterized by 
multiple cholesterol crystal emboli in small arterioles. 
Of note, some studies report the presence of CCE in 
small vessels mostly less than 200 µm in diameter,2,20 
whereas in the current case the size of the affected 
arterioles ranged from 50 to 950 µm in diameter, 
similar to the findings of Flory.1
CONCLUSION
CCE is a type of vasculopathy that occurs when an 
atherosclerotic plaque ruptures and releases cholesterol 
crystals and atheroma debris into downstream arterioles. 
Although the digestive tract is a commonly affected 
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site, CCE is a relatively uncommon cause of colonic 
ischemia overall and as such must be kept in mind 
in the differential diagnosis of ischemia, particularly 
in the setting of a recent vascular procedure and/or 
certain patient-specific risk factors (atherosclerosis, 
smoking, hypercholesterolemia, hypertension, obesity). 
Unfortunately, due to the relatively non-specific 
symptoms, a high degree of clinical suspicion is 
necessary for establishing a timely diagnosis. For the 
pathologist, attention to the character and content of 
the vessels is critical for identification. If not viewed 
carefully, cholesterol clefts may be overlooked as 
artefactual fractioning of vessel lumina rather than 
an indication of a potentially widespread and morbid 
pathologic process.
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